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ABSTRACT: Self-assembly is a fundamental feature of biological systems,
and control of such processes oﬀers fascinating opportunities to regulate
function. Fragaceatoxin C (FraC) is a toxin that upon binding to the surface of
sphingomyelin-rich cells undergoes a structural metamorphosis, leading to the
assembly of nanopores at the cell membrane and causing cell death. In this
study we attached photoswitchable azobenzene pendants to various locations
near the sphingomyelin binding pocket of FraC with the aim of remote
controlling the nanopore assembly using light. We found several constructs in
which the aﬃnity of the toxin for biological membranes could be activated or
deactivated by irradiation, thus enabling reversible photocontrol of pore
formation. Notably, one construct was completely inactive in the thermally
adapted state; it however induced full lysis of cultured cancer cells upon light
irradiation. Selective irradiation also allowed isolation of individual nanopores in artiﬁcial lipid membranes. Photocontrolled
FraC might ﬁnd applications in photopharmacology for cancer therapeutics and has potential to be used for the fabrication of
nanopore arrays in nanopore sensing devices, where the reconstitution, with high spatiotemporal precision, of single nanopores
must be controlled.
■ INTRODUCTION
Biological systems comprise a myriad of molecules, in which
assembly, disassembly, and function must be tightly regulated.
The ability to control such processes remotely using external
stimuli has applications in pharmacology and biotechnology.
Among the existing triggers to modulate biological activities,
light is particularly attractive because it is noninvasive and
allows bioorthogonal control with high spatiotemporal
precision.1−3 In the emerging ﬁeld of photopharmacology,
which was conceptually initiated already ﬁve decades ago,4,5 a
light-responsive small molecule,1,6−11 most frequently an
azobenzene photoswitch, is either covalently attached to the
biological target or incorporated into a drug.1,2,8,10 Azobenzene
photoswitches have two isomers, the thermally stable trans and
the metastable cis, which can be interconverted with light
irradiation (in both directions) or by thermal relaxation (cis to
trans).10 A bioactive compound with the switch introduced
into its structure is preferably nontoxic in its thermally stable
state, while being activated upon irradiation with light. Despite
many successful examples,12−21 one of the main challenges
remaining in the ﬁeld is the lipophilic nature of the commonly
used photoswitches: their introduction into the structure of
known small molecule drugs leads to alteration of pharmaco-
kinetics, solubility, and other key aspects of the bioactive
molecule.
An alternative strategy involves covalent introduction of
photoswitches into bioactive proteins, in particular channels
and pore-forming proteins. Such proteins play an important
role in living organisms for cellular communication,22 exchange
of material23 or act as defense agents.24 Their malfunction, or
in the case of pore-forming toxins their biological function,
causes disruption of cellular activity and often cell death.25,26
Therefore, endogenous protein channels are important
pharmaceutical targets.27−29 Diﬀerent approaches have been
followed attempting to control channels by incorporating
photoswitches.13,30−32 Light-sensitive water-soluble small
molecules were shown to act as inhibitors, causing clogging
or closing of the pore.18,33−40 Furthermore, a photoactive
inhibitor was also covalently attached to the pore close to the
binding site. Upon light irradiation, the photoactive ligand ﬁts
in the binding pocket, thereby closing the channel.13,40−44
Alternatively, a photocleavable group was covalently attached
into the lumen to physically block the ion ﬂux, and upon light
irradiation it was irreversibly cleaved oﬀ, rendering free
passage.45
Rather than controlling the opening and closing of an
endogenous channel, a diﬀerent approach in photopharmacol-
ogy involves controlling the toxicity of a pore-forming toxin
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(PFT) for targeting cancer cells. PFTs are generally excreted as
water-soluble monomeric polypeptides. Multiple copies of
these proteins assemble on the surface of lipid bilayers to form
a nanoscale water conduit that allows passage of molecules
across the membrane (Figure 1A). Attempts to photoregulate
PFTs are very limited, and to the best of our knowledge in the
only example α-hemolysin (αHL) PFT was modiﬁed by
adding a photoremovable 2-nitrobenzyl group to cysteine
residue, previously introduced into a region that was known to
trigger hemolysis. Irradiation with light removed the protecting
group and irreversibly activated the toxin toward red blood
cells.30 However, once activated, the protein was toxic toward
all cells and additional targeting modiﬁcations46,47 would need
to be incorporated into the photoactivated construct.
Indeed, a major challenge in pharmacology, in particular for
cancer drug design, is reducing oﬀ-target toxicity. Toward this
end, recently we showed that the activity of a Fragaceatoxin C
(FraC) PFT, which was modiﬁed to target cancer cells, could
be completely suppressed by extending the transmembrane
region of the protein with a polypeptide. In situ activation
toward cancer cells was obtained by exposing to an
endogenous cancer-speciﬁc protease.48
Here we present a modiﬁed FraC protein whose ability to
form nanopores can be switched on and oﬀ using light (Figure
1B). This modiﬁcation allows in situ activation of FraC and its
subsequent deactivation as it diﬀuses away from the target
region, enabling a possible future use of FraC in chemotherapy.
Except for their potential use as therapeutics, PFT’s including
FraC have also been exploited for nanobiotechnological
applications to sense and detect molecules at a single-molecule
level.49−54 In particular, thousands of individual nanopores are
now integrated in portable and low-cost devices to sequence
DNA.55,56 The ability to control nanopore assembly with light
will greatly reduce the complexity of fabrication of nanopore
arrays.
■ RESULTS
In order to design a photocontrolled FraC nanopore, we
focused on the interaction of the protein with the cell
membrane. The aim was to obtain a toxin for which lipid
binding was inhibited when the protein-appended photoswitch
was in the resting trans state, while promoting lipid binding
and subsequent pore formation upon photoswitching to the cis
isomer. Nine cysteine substitutions were tested (Figure 2D).
Three residues (Q130, E134, and Y138), which are part of the
α2 helix of FraC, were selected because their side chains
pointed directly toward the membrane. K7757 and
W11253,58,59 were chosen because their substitution was
reported to modulate hemolytic activity and membrane
binding. G145, N147, and S166 were selected for their
location in a loop at the protomer interface that faces the
intercalated sphingomyelin lipid. Many of such residues were
also close to or in direct contact with sphingomyelin (Figure
2D), a lipid molecule that triggers FraC oligomerization
(Figure 1A).59,60 Finally, G13 was chosen because it is in the
transmembrane spanning helix (α1) and points toward the
neighboring protomer. For the protein modiﬁcation, four
azobenzene switches were designed and synthesized (for full
experimental details and characterization, see Supporting
Figures S1−S20) for covalent attachment to a cysteine-
modiﬁed FraC via a reactive chloroacetyl moiety (Figure
2A). The switches were designed with diﬀerent substituents at
the para position, where the ﬁrst compound had no additional
substituents (switch A, Figure S21), the second a methoxy
group in order to improve the photoswitching properties61
(switch B, Figure S22), the third a water-soluble negatively
charged sulfonate group (switch C, Figure S23), and the last a
positively charged quaternary ammonium group (switch D,
Figure S26). The switching properties of the synthesized
compounds were studied by NMR and UV−vis spectroscopy
(Figure 2B and 2C, Figures S22−S28). Irradiation at λ = 365
nm switched the azobenzene moiety from the trans to the cis
state, as observed by the decrease in the absorbance at λ = 355
nm and the emergence of new signals in the 1H NMR
spectrum (Figure 2C, peak F). The photostationary state ratio
(PSS ratio), after achieving dynamic equilibrium under
irradiation with 365 nm light, was then calculated by relative
integration of the methylene peaks (Figure 2C, peak F). All
four molecules proved to have high PSS ratios, over 90:10,
when switching to the cis isomer (See Supporting Informa-
tion). However, since switches A and B were not soluble in the
attachment buﬀer (see SI), only switches C and D were used
for further studies.
Azobenzene C was covalently attached to all diﬀerent
cysteine residues introduced in FraC (as conﬁrmed by mass
spectrometry, Figure 2F). The modiﬁed nanopores showed an
additional absorbance peak at λ = 365 nm, typical for the
azobenzene moiety (Figure 2E), and the reversible trans to cis
isomerization could be followed upon irradiation at λ = 365
nm and white light (>450 nm). Numerous switching cycles
could be performed, indicating the stability of the construct
under aqueous conditions (Figure 2G). The cytotoxicity of the
diﬀerent constructs was tested on red blood cells (hemolytic
activity) before and after activation by irradiation with λ = 365
nm light (Figure 2H and Figure S25). Modiﬁcation at
positions 145 and 147 (FraC-G145C-C and FraC-N147C-
C, respectively) resulted in inactive molecules (i.e. they
showed no hemolytic activity). Since both residues are at the
Figure 1. Assembly of photocontrolled nanopore. (A) Mechanism of
FraC (purple) pore formation where sphingomyelin (red) present in
the lipid bilayer (yellow) stabilizes the formed pore. (B) Proposed
mechanism: FraC modiﬁed with a photoswitch (red) does not bind to
the surface of the cell when the azobenzene is in the trans state,
possibly because the charged group in the para position limits the
aﬃnity with the hydrophobic bilayer. The azobenzene can be
reversibly switched to the cis state upon irradiation with light,
allowing binding to the surface of the cell and formation of a pore.
The mature pore structure is stabilized by the cis-azobenzene.
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interface between protomers, most likely the azobenzene
moiety prevented the oligomerization of FraC. For the other
tested positions, the attachment of the switch to the
substituted cysteine residue reduced the activity of the protein,
with notable exception being the attachments at positions 130
and 134 (FraC-Q130C-C and FraC-E134C-C, respectively,
Figure S29). Both residues are in the α2 helix, which resides
right above the membrane (Figure 2D), suggesting that
hydrophobic interactions of the α2 helix facilitate docking of
FraC with the lipid bilayer. Among the variants that were
hemolytically active, modiﬁcations at position 130 showed only
a small diﬀerence between the cis and the trans isoforms.
Modiﬁcation at positions 13, 77 and 166 showed a higher
cytotoxicity for the trans than for the cis isoform, while
modiﬁcations at positions 112, 134 and 138 showed a faster
hemolytic activity for the cis compared to the trans isoform
(Figure 2H and Figure S29).
Since we aimed to obtain a toxin that is activated upon light
irradiation, we selected FraC-Y138C-C, FraC-W112C-C, and
FraC-E134C-C for further characterization. The azobenzene-
modiﬁed constructs were separated from unmodiﬁed FraC
using cation exchange chromatography (Figure S30A). Then
the HC50, which is the hemolytic concentration of toxin
necessary to obtain 50% red blood cell lysis, was tested for the
cis and trans isoforms.
Although all three constructs were more active in the cis
conﬁguration (Figure S31), FraC-Y138C-C showed the largest
diﬀerence between the cis and the trans HC50 values [1.65 ±
0.10 and 6.38 ± 0.69 μM, respectively] (Figure 3A, Figures
S20A and S20B). Notably, 2.2 μM FraC-Y138C-C showed no
hemolytic activity, while irradiation with 365 nm light prior to
Figure 2. Engineering a light-activated toxin. (A) Chemical structures of the azobenzene switch molecules and their activation with light. (B) UV−
vis spectra of switch C (20 μM, 25 °C) before, during irradiation at 365 nm, and after reaching the PSS state as well as back-switching with white
light. Measurements were done in 150 mM NaCl, 15 mM Tris· HCl, pH 7.5. (C) 1H NMR spectra of C (6 mM, 25 °C) in DMSO-d6 before (trans,
purple spectrum) and after irradiation at 365 nm (cis, red spectrum). (D) Cartoon representation of FraC (purple, PDB 4TSY59) bound to lipids
(yellow), showing the amino acids substituted with cysteine (blue spheres), which were then modiﬁed by C. (E) UV−vis spectra of FraC-Y138C-C
(15 μM, 25 °C) before irradiation, during irradiation at 365 nm, and after irradiation with white light. (F) ESI-MS spectra of FraC 138C and FraC-
Y138C-C. (G) Reversible photoswitching of FraC-Y138C-C (15 μM, 25 °C) followed by UV−vis spectroscopy. (H) Comparison of the hemolytic
activity of FraC-C in the cis or trans geometry. For the diﬀerent FraC mutants attached to switch C, the bars show the % of hemolysis induced by
the cis state at the same time point at which the trans state lysed 50% of the red blood cells (t50). Dashed line represents the 50% level at which no
selectivity of cis over trans is observed.
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.9b06998
J. Am. Chem. Soc. 2019, 141, 14356−14363
14358
addition induced complete red blood cell lysis (Figure 3B),
indicating successful design of a photocontrolled FraC
nanopore. Even though we cannot exclude the presence of
trans-labeled monomers in the formed pores, due to a high PSS
ratio (95% cis) the vast majority of the labeled FraC monomers
will be in the cis state. Furthermore, the activated protein could
be switched oﬀ again through irradiation with white light
(Figure 3B in blue). This reversibility was further expanded to
the assay conditions, since active toxins could be deactivated in
the presence of red blood cells by irradiation with white light in
situ (Figure 3C), indicating that the cytotoxicity is reversibly
controlled by light. Substitution of the negatively charged
sulfonate group with a positively charged quaternary
ammonium group also showed cis versus trans selectivity but
did not improve the overall transition eﬃciency (Figure S32).
Finally, we tested the cytotoxicity of FraC-Y138C-C toward
human cancer cells to test its usefulness as a chemotherapeutic
agent. Addition of up to 1.1 μM trans FraC-Y138C-C to A431
epidermoid carcinoma cells did not cause any cell death, while
an equal concentration of cis showed cytotoxicity [LD50 = 0.93
± 0.05 μM] (Figure 3D and Figure S33). This result indicates
that light-activated toxins could function toward a variety of
eukaryotic cells. Furthermore, at the concentration in which
the cis isomer showed complete killing of A431 cancer cells,
the trans isomer did not show any hemolytic activity toward
healthy red blood cells, pointing toward the usefulness of the
construct in photoactivated tumor therapy. Since the activity of
FraC nanopores is enhanced by the presence of sphingomyelin
in the target cell membrane, the sphingomyelin-rich cells are
more vulnerable to the toxin. Therefore, there is a slight
diﬀerence in potency of the cis isomer for the cancer cells
(LD50 = 0.93 ± 0.05 μM) and red blood cells (HC50= 1.65 ±
0.10 μM). This diﬀerence is more pronounced if in the
hypothetical therapeutic scenario one compares the potency
toward cancer cells in the photoactivated area (cis isomer) with
its toxicity in the nonirradiated blood pool (HC50 = 6.38 ±
0.69 μM).
Alongside potential use as a cancer therapeutic, FraC has
been used as a single-molecule sensor. In its oligomeric form,
FraC forms nanopores in artiﬁcial lipid bilayers. Under an
applied transmembrane potential, the induced ionic current
across single nanopores (Figure 4A) was used to identify and
study single molecules, including DNA,52 peptides, and
proteins.53,54 Most notably, arrays of thousands of nanopores
are now embedded into commercial DNA sequencing devices.
Insertion of a single nanopore in a sensing device, however, is a
stochastic process that cannot be fully controlled. Thus, a
nanopore whose bilayer insertion can be controlled with light
would speed up analysis and reduce the cost of multiplexing in
nanopore sensing devices. Therefore, we tested the ability of
our constructs to reversibly form nanopores in lipid bilayers. It
was found that the trans isomer of FraC-S166C-C (Figure
S34), which showed high hemolytic activity (Figure 2H), also
forms single pores, while the trans isomer of FraC-Y138C-C
could not form nanopores (Figure 4B). The direct irradiation
of the electrophysiology chamber with 365 nm light, forming
the cis isomer of FraC-Y138C-C, activated the nanopores as
shown by stepwise increases of the bilayer conductance
reﬂecting individual insertions into the planar lipid bilayer
(Figure 4C). Subsequent in situ irradiation with white light
almost completely inhibited further assembly of FraC nano-
pores (Figures 4D and S35). By contrast, the nanopores that
were already inserted in the lipid bilayer were not aﬀected by
irradiation with white light.
Figure 3. Light-activated toxin. (A) Comparison of the hemolysis percentage of FraC-Y138C-C in the cis state (irradiation at 365 nm, red spheres)
and trans state (no irradiation, purple squares and irradiation with white light, blue triangles). (B) In the trans state (no irradiation, purple spheres)
FraC-Y138C-C is not hemolytically active. The conversion to the cis state (irradiation at 365 nm, red triangles) triggers the hemolytic activity of the
nanopore. Nanopore solutions ﬁrst activated by irradiation at 365 nm and then deactivated with white light (blue triangles) are not hemolytically
active. (C) The activity of pre-activated FraC-Y138C-pSO3 (pink squares) can be reversed by irradiation of the red blood cells with white light
(purple triangles) a certain time after the beginning of the assay (red circles). (D) Toxicity of FraC-Y138C-C towards A431 cancer cells. Activated
FraC-Y138C-C (irradiation at 365 nm, red triangle) is cytotoxic, while deactivated FraC-Y138C-C (irradiated with white light, purple spheres)
does not kills the cells.
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Deactivation of FraC is advantageous in nanopore analysis
because, once a single nanopore is reconstituted, irradiation
with white light hinders further insertions (Figure 4E).
Previously, we showed that FraC can assemble into hexameric
(type III, inner constriction 0.9 nm), heptameric (type II, inner
constriction 1.2 nm), and octameric (type I, inner constriction
1.6 nm) nanopores depending on the preoligomerization
conditions.53 FraC-Y138C-C nanopores showed a unitary
conductance of 0.44 nS (+50 mV), which most likely
corresponded to type III FraC nanopores (Figure 4F). This
is advantageous, because type III FraC, which is the smallest
nanopore characterized to date, could only be eﬃciently
obtained at pH 4.5 but not at physiological pH.53 Furthermore,
FraC-Y138C-C could be assembled in the absence of
sphingomyelin, and it showed a more stable conductance at
positive applied potential compared to unmodiﬁed FraC
nanopores (Figure 4G), suggesting that the introduced
hydrophobic moiety most likely stabilized the nanopore in
planar lipid bilayers.
■ DISCUSSION AND CONCLUSIONS
In this work we show that the assembly of the pore-forming
toxin FraC from Actinia f ragacea on lipid bilayers can be
reversibly controlled by using light as an external trigger. The
oligomerization of FraC nanopores is triggered by sphingo-
myelin, which lines the pore wall and acts as assembly
cofactor.59 Hence, we attached an azobenzene, a light-
responsive molecule, to a cysteine introduced at various
other positions in FraC. In particular, we selected several
residues near the binding site of sphingomyelin, hoping to
substitute the role of sphingomyelin as membrane anchor with
the azobenzene. Azobenzenes were chosen due to their
relatively high photostationary states and quantum yields as
well as fast photoisomerization and low rates of photo-
bleaching.8,10 The azobenzene moiety was further modiﬁed by
introduction of charged groups in the para position (sulfonate
and quaternary ammonium) to increase water solubility. The
additional charged group was also expected to introduce a
diﬀerent orientation and charge to the switch. In turn, this was
anticipated to result in a diﬀerential aﬃnity of FraC monomers
Figure 4. Light-activated nanopore. (A) Schematic representation of the nanopore experiment showing a FraC nanopore (purple) inserted in a
planar lipid bilayer (blue). (B) Addition of 4 μM FraC-Y138C-C (trans conformation) to the cis side of an electrophysiology chamber (500 μL) did
not induce the formation of nanopores, as shown by the lack of changes of the bilayer conductance. Every few minutes the bilayer was reformed
(red asterisk) to ensure a stable bilayer formation. (C) About 10 min after irradiating the electrophysiology chamber with UV light at λ = 365 nm,
stepwise insertions of several nanopores are observed as detected by discrete current enhancements. (D) Subsequent irradiation of the cis chamber
(5 min, white light) prevented insertion of additional nanopores. (E) After a single FraC-Y138C-C was reconstituted, insertion of additional
nanopores was prevented by irradiating with white light. (F and G) Relationship between current and voltage for single FraC-Y138C-C nanopores.
Solution used for the electrical recording contained 1 M NaCl, 15 mM TrisHCl, pH 7.5. Current traces from B to E were collected applying +50
mV, a Bessel low-pass ﬁlter with 2 kHz cutoﬀ, and sampled at 10 kHz at room temperature (25 °C).
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for the lipid membrane in the cis and trans isomeric forms.
Rewardingly, we found that attachment of the azobenzene to
positions near the sphingomyelin binding site granted several
constructs that were inactive in the thermal resting state (trans
azobenzene isomer) but active in the light excited state (cis
azobenzene isomer). Interestingly, we could observe oligome-
rization of FraC-Y138C-C in the absence of sphingomyelin,
suggesting that the azobenzene can substitute the sphingo-
myelin to promote pore formation.60 Importantly, at selected
concentrations one variant (FraC-Y138C-C) was completely
inactive in the trans state while inducing full cell death in the
cis state (Figure 3A and 3B). The cytotoxicity of photo-
controlled FraC could be completely stopped by irradiation
with white light (Figure 3C), hence providing reversible
control of activity. There are multiple events that can be
aﬀected by the presence of the switch including binding to the
surface of the target cell, oligomerization, and subsequent
prepore formation or insertion of the mature pore into the
lipid bilayer. Although further research is needed to precisely
pinpoint the nature of photoregulation in the presented
system, the observation that pores can no longer dissociate
from the membrane suggests that the prepore to pore
transition might not be controlled by the light switch. The
azobenzene photoswitch was attached at the interface with the
membrane rather than at the protomer interface; hence, a
likely explanation is that the switching from trans to cis
regulates the interaction with the membrane as proposed in
Figure 1.
Light is an ideal external stimulus in pharmacology due to its
noninvasive and biorthogonal properties as well as giving
spatiotemporal control.8,10 Hence, FraC nanopores decorated
with a light-sensitive switch provide a new valuable photo-
pharmacology tool. The reversibility of nanopore formation
provides a potential use for clinical applications where the
inactive toxin gets locally activated on a tumor site which is
irradiated. Because of diﬀusion, the active monomer poses a
threat to the neighboring tissue; the area around the tumor can
then be irradiated with white light to switch oﬀ the diﬀused
active toxins.
While irradiation with UV light is not ideal mainly because
of the limited penetration depth, potential damage to living
tissue, and interference with switching in blood,3,62 introducing
a visible light switch is the next step. Furthermore, alternative
modiﬁed triggers could be introduced to further target the
cytotoxicity of FraC.48
A light-responsive FraC might also be advantageous in
biosensing applications. It has been shown that single FraC
nanopores reconstituted in artiﬁcial lipid bilayers can be used
to detect and study single molecules, such as DNA,52 peptides,
and proteins.53,54 Importantly, the output signal, which is the
ionic current ﬂowing through individual nanopores, can be
integrated in portable and low-cost devices containing
thousands of individual pores. Here we showed that once a
single nanopore is inserted, the excess of active nanopores in
solution can be deactivated by irradiation with white light,
greatly reducing the probability of a second insertion. In turn,
this would facilitate precise preparation of arrays of single
nanopores, thus reducing the cost of multiplexing.
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(21) Pittolo, S.; Goḿez-Santacana, X.; Eckelt, K.; Rovira, X.; Dalton,
J.; Goudet, C.; Pin, J.-P.; Llobet, A.; Giraldo, J.; Llebaria, A.; et al. An
Allosteric Modulator to Control Endogenous G Protein-Coupled
Receptors with Light. Nat. Chem. Biol. 2014, 10 (10), 813−815.
(22) Clapham, D. E. TRP Channels as Cellular Sensors. Nature
2003, 426 (6966), 517−524.
(23) Matsuzaki, T.; Tajika, Y.; Tserentsoodol, N.; Suzuki, T.; Aoki,
T.; Hagiwara, H.; Takata, K. Aquaporins: A Water Channel Family.
Kaibogaku Zasshi 2002, 77 (2), 85−93.
(24) Peraro, M. D.; van der Goot, F. G. Pore-Forming Toxins:
Ancient, but Never Really out of Fashion. Nat. Rev. Microbiol. 2016,
14 (2), 77−92.
(25) Zaydman, M. A.; Silva, J. R.; Cui, J. Ion Channel Associated
Diseases: Overview of Molecular Mechanisms. Chem. Rev. 2012, 112
(12), 6319−6333.
(26) Kasianowicz, J. J. Introduction to Ion Channels and Disease.
Chem. Rev. 2012, 112 (12), 6215−6217.
(27) Gorostiza, P.; Isacoff, E. Y. Nanoengineering Ion Channels for
Optical Control. Physiology 2008, 23 (5), 238−247.
(28) Bregestovski, P. D.; Maleeva, G. V. Photopharmacology: A
Brief Review Using the Control of Potassium Channels as an
Example. Neurosci. Behav. Physiol. 2019, 49 (2), 184−191.
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